Objective: To describe clinical characteristics, resource use, outcomes, and to identify
predictors of in-hospital mortality of patients with COVID-19 admitted to the intensive care …

Background The COVID‐19 pandemic has disrupted medical care, increased isolation, and
exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer. org …

Patients with a diagnosis of lung cancer are often vulnerable to infection, and the risk is
increased by tumor-associated immunosuppression and the effects of the treatments …

Ductal carcinoma in situ (DCIS) is an intraepithelial breast neoplasm accounting for up to
25% of US breast cancers. 1, 2 Treatment for this nonlethal diagnosis remains controversial …

Background Patients with cancer are at high risk for severe coronavirus disease 2019
(COVID-19) infection. Knowledge regarding the efficacy of the messenger RNA (mRNA) …

Given the rapidly expanding global spread of the SARS-Co-V-2 virus and the expanding
number of individuals with the serious and potentially fatal illness, COVID-19, there is an …

Patients with hematologic malignancies have both an increased risk for severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and higher morbidity/mortality …

Patients with cancer are more susceptible to a higher risk of coronavirus infection and its
severe complications than the general population. In addition, these patients were not …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2, has currently affected> 220 million individuals worldwide. The …

Background COVID‐19 infection delays therapy and in‐person evaluation for oncology
patients, but clinic clearance criteria are not clearly defined. Methods We conducted a …